101 related articles for article (PubMed ID: 3427548)
1. Effect of short-term administration of vasopressin on arterial pressure and norepinephrine turnover in Long-Evans rats.
Kline RL; Chow KY; Mercer PF
Can J Physiol Pharmacol; 1987 Oct; 65(10):2142-6. PubMed ID: 3427548
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous infusions of vasopressin and angiotensin II on central and peripheral noradrenergic function in conscious rabbits.
Patel KP; Whiteis CA; Lund DD; Schmid PG
Can J Physiol Pharmacol; 1987 May; 65(5):765-72. PubMed ID: 3621038
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and humoral consequences of chronic infusion of vasopressin in conscious rats.
Tsuchihashi T; Takata Y; Nakao Y; Tominaga M; Takishita S; Kobayashi K; Abe I; Fujishima M
Clin Exp Pharmacol Physiol; 1993; 20(7-8):489-95. PubMed ID: 8403529
[TBL] [Abstract][Full Text] [Related]
4. Enhanced noradrenergic activity in kidney of Brattleboro rats with diabetes insipidus.
Kline RL; Patel KP; Mercer PF
Am J Physiol; 1986 Apr; 250(4 Pt 2):R567-72. PubMed ID: 3963226
[TBL] [Abstract][Full Text] [Related]
5. Chronic intravenous administration of V1 arginine vasopressin agonist results in sustained hypertension.
Cowley AW; Szczepanska-Sadowska E; Stepniakowski K; Mattson D
Am J Physiol; 1994 Aug; 267(2 Pt 2):H751-6. PubMed ID: 8067431
[TBL] [Abstract][Full Text] [Related]
6. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension.
Szczepanska-Sadowska E; Stepniakowski K; Skelton MM; Cowley AW
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1217-25. PubMed ID: 7977848
[TBL] [Abstract][Full Text] [Related]
7. Long-term influence of vasopressin on the control of arterial blood pressure independent of volume changes.
Cowley AW; Skelton MM; Merrill DC
J Hypertens Suppl; 1984 Dec; 2(3):S337-9. PubMed ID: 6599677
[TBL] [Abstract][Full Text] [Related]
8. Effect on pressor and vascular responsiveness in rabbits of drugs that decrease norepinephrine uptake.
Koivunen DG; Johnson JA
Proc Soc Exp Biol Med; 1994 Sep; 206(4):375-83. PubMed ID: 8073046
[TBL] [Abstract][Full Text] [Related]
9. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
[TBL] [Abstract][Full Text] [Related]
10. Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion.
Yamaguchi K; Watanabe K
Brain Res Bull; 2005 Jul; 66(1):59-69. PubMed ID: 15925145
[TBL] [Abstract][Full Text] [Related]
11. Regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats.
Bennett T; Mahajan RP; March JE; Kemp PA; Gardiner SM
Br J Anaesth; 2004 Sep; 93(3):400-7. PubMed ID: 15220167
[TBL] [Abstract][Full Text] [Related]
12. Long-term blood pressure and metabolic effects of vasopressin with servo-controlled fluid volume.
Cowley AW; Merrill DC; Quillen EW; Skelton MM
Am J Physiol; 1984 Sep; 247(3 Pt 2):R537-45. PubMed ID: 6383081
[TBL] [Abstract][Full Text] [Related]
13. Activation of renal sympathetic outflow by intracisternal hypertonic NaCl in dogs.
Abe I; Averill DB; Ferrario CM
Am J Physiol; 1989 Feb; 256(2 Pt 2):H411-6. PubMed ID: 2644846
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats.
Li P; Morris M; Ferrario CM; Barrett C; Ganten D; Callahan MF
Am J Physiol; 1998 Oct; 275(4):H1130-7. PubMed ID: 9746459
[TBL] [Abstract][Full Text] [Related]
15. Genetic AVP deficiency abolishes cold-induced diuresis but does not attenuate cold-induced hypertension.
Sun Z
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1472-7. PubMed ID: 16396942
[TBL] [Abstract][Full Text] [Related]
16. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
Ishikawa S; Schrier RW
Am J Physiol; 1984 Jan; 246(1 Pt 2):H104-13. PubMed ID: 6364835
[TBL] [Abstract][Full Text] [Related]
17. Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats.
Delle M; Ricksten SE; Häggendal J; Olsson K; Skarphedinsson JO; Thorén P
J Pharmacol Exp Ther; 1990 May; 253(2):646-54. PubMed ID: 2187076
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenergic stimulation and vasopressin in congestive heart failure.
Goldsmith SR; Dodge-Brown DL; Katz A
J Cardiovasc Pharmacol; 1989 Sep; 14(3):425-9. PubMed ID: 2476622
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of renal sympathetic activity and heart rate by vasopressin in hemorrhaged diabetes insipidus rats.
Peuler JD; Schmid PG; Morgan DA; Mark AL
Am J Physiol; 1990 Mar; 258(3 Pt 2):H706-12. PubMed ID: 2316685
[TBL] [Abstract][Full Text] [Related]
20. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
